So much of the joy of Christmas is eating and drinking with wild abandon and dealing with the consequences for your waistline ...
Weight-loss drugs are typically not covered by private insurance plans, and in late November, President Joe Biden proposed expanding coverage for these medications for Americans insured by Medicare ...
A new crop of evidence — both anecdotal and research based — is pointing to these drugs as a potential option for people ...
Last week, the Biden administration passed a rule allowing for the government healthcare programs Medicare and Medicaid ...
As Ozempic keeps flying off the shelves, more and more people are taking the drug into their own hands by "microdosing" it.
Novo Nordisk is a bargain stock with tremendous growth potential. Vertex Pharmaceuticals has seven clear paths to growth ...
Patients self-administer the drug using a pre-dosed injector pen, but Lilly recently introduced the product in single-dose ...
MONTGOMERY — A joint task force charged with researching and proposing solutions for Alabama’s high obesity and diabetes ...
The holidays are a time known for feasting on delicious food, but that might not be possible for people taking weight-loss drugs.
The expansion of a newly acquired facility in Wisconsin is Lilly’s largest U.S. manufacturing investment outside of Indiana ...
Conversely, Eduardo Grunvald, MD, medical director of the weight management program at UC San Diego Health, sees less of an ...